OTHER INCOME	12 Months Ended
Dec. 31, 2023
Other Income and Expenses [Abstract]
OTHER INCOME	16. OTHER INCOME During the year ended December 31, 2023, the Company had $369,857 other income, mainly consisted of local government grant for supporting Runcangsheng to become leading enterprise for plant, producing and marketing Chinese herbal medicine by utilizing local and natural resource of Chinese herb, building a primary processing plant with an annual processing capacity of 1,500 tons of Chinese medicinal materials, as well as supporting Runcangsheng on integrated innovation and application of deep processing technology for health products.

The entire disclosure for other income or other expense items (both operating and nonoperating). Sources of nonoperating income or nonoperating expense that may be disclosed, include amounts earned from dividends, interest on securities, profits (losses) on securities, net and miscellaneous other income or income deductions.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 720
-Name Accounting Standards Codification
-Publisher FASB
-URI https://asc.fasb.org/720/tableOfContent

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Accounting Standards Codification
-Topic 610
-Publisher FASB
-URI https://asc.fasb.org/610/tableOfContent

Name:	us-gaap_OtherIncomeAndOtherExpenseDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration